Sorrento Therapeutics, Inc.
Main Office: 4955 Directors Place | San Diego | CA | 92121

Sorrento Therapeutics, Inc.

San Diego


Sorrento Therapeutics, Inc (Nasdaq: SRNE) is a clinical stage, antibody-centric, biopharmaceutical company developing new therapies to turn malignant cancers into manageable and possibly curable diseases. Cancers are genetically diverse, highly adaptive, constantly mutating and virtually invisible to the immune system. Therefore, we believe any single target therapy is destined to fail. Our approach to cancer therapy is based on the belief that patients will require a multimodal multipronged approach – targeting a single or diverse set of cellular targets and attacking those on several fronts – simultaneously or sequentially, frequently and relentlessly.

Legal Jobs in San Diego and Near Locations